(19)
(11) EP 4 395 900 A1

(12)

(43) Date of publication:
10.07.2024 Bulletin 2024/28

(21) Application number: 22786885.8

(22) Date of filing: 02.09.2022
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
A61K 31/35(2006.01)
C07D 493/20(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 493/20; A61P 35/00
(86) International application number:
PCT/EP2022/074454
(87) International publication number:
WO 2023/031402 (09.03.2023 Gazette 2023/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.09.2021 EP 21306210

(71) Applicants:
  • Centre National de la Recherche Scientifique
    75016 Paris (FR)
  • Institut Curie
    75248 Paris Cedex 05 (FR)
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    75013 Paris (FR)
  • Adam Mickiewicz University
    61-614 Poznan (PL)

(72) Inventors:
  • RODRIGUEZ, Raphaël
    30210 Vers-Pont-du-Gard (FR)
  • CZERWONKA, Dominika
    61-619 Poznan (PL)
  • ANTOSZCZAK, Michal
    62-003 Biedrusko (PL)
  • HUCZYNSKI, Adam
    61-680 Poznan (PL)

(74) Representative: Novagraaf Technologies 
Bâtiment O2 2, rue Sarah Bernhardt CS90017
92665 Asnières-sur-Seine Cedex
92665 Asnières-sur-Seine Cedex (FR)

   


(54) NITROGEN-CONTAINING DERIVATIVES OF SALINOMYCIN, SYNTHESIS AND USES THEREOF